Internal Medicine Journal

Cover image for Vol. 46 Issue 11

Edited By: Jeff Szer

Impact Factor: 1.526

ISI Journal Citation Reports © Ranking: 2015: 65/155 (Medicine General & Internal)

Online ISSN: 1445-5994

Recently Published Issues

See all

Top 5 Cited Papers - 2013 Impact Factor Period

Variability in vitamin D assays impairs clinical assessment of vitamin D status
J. K. C. Lai, R. M. Lucas, E. Banks, A.-L. Ponsonby and the Ausimmune Investigator Group

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
G. Cheng, C. Huang, H. Deng and H. Wang

Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies
M. Dugar, S. Cox, V. Limaye, P. Blumbergs and P. J. Roberts-Thomson

Use of empiric antimicrobial therapy in neutropenic fever
C. S. Tam, M. O'Reilly, D. Andresen, S. Lingaratnam, A. Kelly, K. Burbury, J. Turnidge, M. A. Slavin, L. J. Worth, L. Dawson and K. A. Thursky

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication
D. Tong, N. Manolios, G. Howe and D. Spencer

Editor's Choice

Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma

D. Day, Y. Kanjanapan, E. Kwan, D. Yip, N. Lawrentschuk, I. D. Davis, A. A. Azad, S. Wong, M. Rosenthal, P. Gibbs and B. Tran

The role of cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) in the era of targeted therapies is currently undefined. In recent years, neutrophil-to-lymphocyte ratio (NLR) has emerged as a prognostic marker in several cancers, including mRCC.

SEARCH

SEARCH BY CITATION